超声引导衰减参数测量衰减系数评估肝脂肪变性的效用:与MRI质子密度脂肪分数的比较
本研究纳入126例慢性肝病(非乙型、非丙型肝炎)患者,以MRI质子密度脂肪分数(PDFF)为参考标准,评估超声引导衰减参数(UGAP)所测衰减系数诊断肝脂肪变性的能力。衰减系数与PDFF值呈强相关(r=0.746),对PDFF确定的脂肪变性分级≥1、≥2和3级的诊断AUC分别为0.922、0.874和0.892。结论认为UGAP所测衰减系数对检测肝脂肪变性具有良好的诊断能力。
要点
- UGAP衰减系数与MRI-PDFF强相关(r=0.746),可用于无创评估肝脂肪变性。
- 对PDFF分级≥1、≥2、3级脂肪变性的诊断AUC分别为0.922、0.874、0.892。
- 轻度或无脂肪变性(分级≤1)患者中相关性较弱(r=0.559)。
核心结论
- UGAP所测衰减系数对检测肝脂肪变性具有良好的诊断能力。
研究设计与样本
- 共分析126例慢性肝病(非乙型、非丙型肝炎)患者,以MRI测定的质子密度脂肪分数(PDFF)为参考标准,采用ROC曲线分析评估UGAP衰减系数的诊断能力,并分析其与PDFF值的相关性。
诊断标准与关键数值
- 衰减系数与PDFF值的相关系数r=0.746(95%CI 0.657-0.815,p<0.001)。
- PDFF确定的脂肪变性分级≥1、≥2、3级的诊断AUC分别为0.922(95%CI 0.870-0.973)、0.874(95%CI 0.814-0.934)、0.892(95%CI 0.835-0.949)。
- 轻度或无脂肪变性(分级≤1)患者中,衰减系数与PDFF值的r=0.559(95%CI 0.391-0.705,p<0.001)。
- 肥胖患者(BMI≥25)中,衰减系数与PDFF值的r=0.773(95%CI 0.657-0.853,p<0.001)。
- 肥胖患者中,PDFF确定的脂肪变性分级≥1、≥2、3级的诊断AUC分别为0.884(95%CI 0.792-0.976)、0.863(95%CI 0.778-0.947)、0.889(95%CI 0.813-0.965)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Recently, a new method was developed to diagnose hepatic steatosis by measuring attenuation coefficients that are based on the ultrasound-guided attenuation parameter (UGAP). We investigated the diagnostic ability of these coefficients to detect steatosis that was identified using the proton density fat fraction (PDFF) on MRI in patients with chronic liver disease.
MATERIALS AND METHODS: A total of 126 patients with chronic liver disease (non-hepatitis B, non-hepatitis C) were analyzed. The diagnostic ability of UGAP-determined attenuation coefficients was evaluated using ROC curve analysis, and the correlation between MRI-determined PDFF values and attenuation coefficient values was determined.
RESULTS: The correlation coefficient (r) between PDFF values and attenuation coefficient values was 0.746 (95% CI, 0.657-0.815) (p < 0.001), corresponding to a strong relationship. The diagnostic ability of attenuation coefficients for steatosis grades ≥ 1, ≥ 2, and 3 as determined by PDFF were 0.922 (95% CI, 0.870-0.973), 0.874 (95% CI, 0.814-0.934), and 0.892 (95% CI, 0.835-0.949), respectively. The r between PDFF values and attenuation coefficient values was 0.559 (95% CI, 0.391-0.705) (p < 0.001) in patients with mild or no steatosis (grade ≤ 1). In addition, the r between PDFF values and attenuation coefficient values was 0.773 (95% CI, 0.657-0.853) (p < 0.001) in obese patients (body mass index [weight in kilograms divided by the square of height in meters] ≥ 25). The diagnostic ability of attenuation coefficients for patients with steatosis grades ≥ 1, ≥ 2, and 3 as determined by PDFF were 0.884 (95% CI, 0.792-0.976), 0.863 (95% CI, 0.778-0.947), and 0.889 (95% CI, 0.813-0.965), respectively.
CONCLUSION: UGAP-determined attenuation coefficient values had a good diagnostic ability to detect hepatic steatosis.
引用
- Tada T, Kumada T, Toyoda H, et al. Utility of Attenuation Coefficient Measurement Using an Ultrasound-Guided Attenuation Parameter for Evaluation of Hepatic Steatosis: Comparison With MRI-Determined Proton Density Fat Fraction. AJR Am J Roentgenol. 2018. PMID: 30476453. doi:10.2214/AJR.18.20123
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。